Opendata, web and dolomites


Complete Automatization of Tissue Microarray Systems: Unleashing High-Throughput in Pathology Diagnosis, Prognosis and Anticancer Therapy

Total Cost €


EC-Contrib. €






 Prometeo project word cloud

Explore the words cloud of the Prometeo project. It provides you a very rough idea of what is the project "Prometeo" about.

worldwide    earn    400    basic    practical    markers    world    confirming    scanner    commercializing    slicer    team    human    serious    routine    society    creates    technique    isenet    tissues    automatizing    12m    cancers    workload    tma    tmas    97    full    purpose    multiple    companies    barely    fact    designing    solves    243    qualified    global    helping    molecular    commercialization    generate    automatic    reduce    prometeo    recognition    standard    performing    employees    reproducibility    hindering    donors    clinical    algorithms    reagent    waste    image    efficient    successful    cumulative    manually    hire    consist    niche    reducing    manual    microarray    additional    break    91    analysed    diagnostic    arrayer    market    sell    tedious    semi    unfortunately    automated    ingredients    few    automatize    starts    samples    tool    preventing    almost    profit    bottleneck    attempts    manner    prognostic    slide    2018    simultaneously    besides    involve    laboratories    tissue    throughput    patient    billion    benefits   

Project "Prometeo" data sheet

The following table provides information about the project.


Organization address
address: Via Volturno CEDRI 80
postcode: 20816

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Project website
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-11-01   to  2017-02-28


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 


 Project objective

Tissue microarray (TMA) is a practical and effective tool for molecular analysis of tissues that is helping identify new diagnostic and prognostic markers and targets in human cancers. In fact, the global microarray market is estimated to reach €6.7 billion by 2018. However, the manual steps of the TMA technique are a serious bottleneck as they are preventing high throughput analysis of multiple samples from multiple donors. Although many attempts have been done (confirming the market niche) to automatize TMAs, just few companies have products on the market which are more efficient that performing the technique manually. Unfortunately, these products use semi-automatic procedures which involve many tedious manual steps, and they are barely used by researchers.

PROMETEO is a fully automated TMA system for routine clinical use in a high-throughput manner. It solves the bottleneck which is currently hindering diagnostic and research laboratories. Our project consist on improving and automatizing three devices: Tissue arrayer (sample slicer); Slide scanner; and the Whole Slide Image recognition algorithms.

It benefits end users and society because the TMA technology will reduce diagnostic costs since over 400 patient samples can be analysed simultaneously, without additional workload, reducing tissue sample and reagent waste. Furthermore, it increases reproducibility of the results and creates a standard method.

ISENET has the ingredients to be successful developing PROMETEO because, besides their highly qualified team, they have experience in designing and commercializing TMA equipment all over the world for 20 years.

We have estimated that during the five years after commercialization starts, we will sell worldwide 91 full automated PROMETEO TMAs and 243 basic TMAs. For that purpose, we will hire 8 new technical employees. We will earn almost €12M cumulative profit, break even the second year, and generate a R.O.I of 6.97 by commercializing PROMETEO.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PROMETEO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PROMETEO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

PanCareFollowUp (2019)

PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregivers

Read More  

HAP2 (2020)

Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia

Read More  

GACD (2019)

Global Alliance for Chronic Diseases Secretariat

Read More